Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Aurora A anticorps (N-Term)

AURKA Reactivité: Humain, Souris, Rat, Chien WB Hôte: Souris Monoclonal 7F12 unconjugated
N° du produit ABIN492608
  • Antigène Voir toutes Aurora A (AURKA) Anticorps
    Aurora A (AURKA) (Aurora Kinase A (AURKA))
    Épitope
    • 22
    • 15
    • 8
    • 8
    • 8
    • 6
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 110
    • 72
    • 40
    • 20
    • 18
    • 14
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    Humain, Souris, Rat, Chien
    Hôte
    • 110
    • 17
    • 1
    Souris
    Clonalité
    • 104
    • 23
    Monoclonal
    Conjugué
    • 74
    • 9
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Aurora A est non-conjugé
    Application
    • 94
    • 52
    • 32
    • 24
    • 15
    • 11
    • 11
    • 8
    • 6
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    Recognizes Aurora-A (N-term).
    Attributs du produit
    Synonyms: AURKA, AIK1, ARK1, AURA, BTAK, STK15, STK6, Aurora/IPL1-related kinase 1, AURORA2,Serine/threonine-protein kinase 6, Serine/threonine kinase 15, Breast tumor-amplifiedkinase
    Purification
    Size Exclusion Chromatography.
    Ingrédients
    incl. positive Control
    Immunogène
    Peptide conjugated to hemocyaninEpitope: N-terminus.
    Clone
    7F12
    Isotype
    IgG1
    Top Product
    Discover our top product AURKA Anticorps primaire
  • Indications d'application
    Immunobotting (Western Blot): 0.5 μg/mL for HRPO/ECL detection. Recommended blocking buffer: Casein/Tween 20 based blocking buffer and blotincubation buffer. Included Postitive Control: Cell Lysate from untreated A431 cells.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Protocole
    Positive Control: Cell Lysate from untreated A431 cells. Formulation: Lyophilized Cell lysate from Serum starved A431 cells. Stability: Reconstitute by addition of 200 µl H2O. After complete solubilization add 200 µl 2xSDS-PAGE sample buffer, mix and incubate at 90°C for 5 min. Application: The Positive Control lysate is recommended for Immunoblot applications. 20µl of PositiveControl correspond to ca. 20. 000 cells. Use 20µl/lane (mini gel) for HRPO/ECL detection of the target proteins. Storage: Aliquote and store frozen. Avoid repeated freeze/thaw cycles. Shelf life: one year from despatch. The Lyophilized cell lysates contain SDS and are not recommended for applications withnative proteins such as Immunoprecipitation.
    Restrictions
    For Research Use only
  • Reconstitution
    Restore with 1 mL H2O (15 min, RT).
    Buffer
    PBS / 0.09 % Sodium Azide / PEG and Sucrose.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store lyophilized (preferably in a desiccator) at -20 °C and reconstituted (aliquote andfreeze in liquid nitrogen) at -20 °C to -80 °C. Avoid repeated freezing and thawing. Thaw aliquots at 37 °C. Thawed aliquots may be stored at 2-8 °C up to 3 months.
    Shelf life: one year from despatch.
    Date de péremption
    12 months
  • Antigène
    Aurora A (AURKA) (Aurora Kinase A (AURKA))
    Autre désignation
    Aurora Kinase A (AURKA Produits)
    Synonymes
    anticorps AIK, anticorps ARK1, anticorps AURA, anticorps AURORA2, anticorps BTAK, anticorps PPP1R47, anticorps STK15, anticorps STK6, anticorps STK7, anticorps AIRK1, anticorps AU019385, anticorps AW539821, anticorps Ark1, anticorps Aurora-A, anticorps Ayk1, anticorps IAK, anticorps IAK1, anticorps Stk6, anticorps 87A7-9/2, anticorps Aur-A, anticorps AurA, anticorps CG3068, anticorps Dmel\\CG3068, anticorps aur-A, anticorps aurA, anticorps ck10, anticorps ck[10], anticorps l(3)87Ac, anticorps l(3)ck10, anticorps ARK-1, anticorps Eg2, anticorps aik, anticorps ark1, anticorps aur-a, anticorps aura, anticorps aurka-a, anticorps aurora2, anticorps btak, anticorps stk15, anticorps stk6, anticorps stk7, anticorps pEg2, anticorps wu:fb37c10, anticorps wu:fc02c02, anticorps zgc:100912, anticorps AURKA, anticorps aurka, anticorps aurora kinase A, anticorps aurora A, anticorps aurora kinase A L homeolog, anticorps hypothetical protein, anticorps aurora kinase A S homeolog, anticorps AURKA, anticorps Aurka, anticorps aurA, anticorps aurka.L, anticorps aurka, anticorps Aurora-A, anticorps aurka.S
    Sujet
    Aurora proteins are members of a serine/threonine kinase family. They play a crucial role in mitosis by regulating chromosome segregation and cytokinesis. There are three forms of Aurora proteins in mammalian cells: AuroraA, B and C. Aurora-A (Aurora-2, STK6, ARK1, Aurora/IPL-1 related kinase) associates with centrosomes and microtubules during mitosis. Phosphorylation of a threonine residue within the activation loop of the catalytic domain lead to activation of Aurora-A. AuroraB (Aurora-1) is responsible for chromatin modification and histone H3 phosphporylation.Synonyms: AIK1, ARK1, AURA, AURKA, AURORA2, Aurora/IPL1-related kinase 1, BTAK, Breast tumor-amplified kinase, STK15, STK6, Serine/threonine kinase 15, Serine/threonine-protein kinase 6
    ID gène
    6790
    UniProt
    O14965
    Pathways
    Cycle Cellulaire, Asymmetric Protein Localization
Vous êtes ici:
Support technique